In: Nature communications, 2016, vol. 7, p. 13466
Neutralization of the common p40-subunit of IL-12/23 in psoriasis patients has led to a breakthrough in the management of moderate to severe disease. Aside from neutralizing IL-23, which is thought to be responsible for the curative effect, anti-p40 therapy also interferes with IL-12 signalling and type 1 immunity. Here we dissect the individual contribution of these two cytokines to the...
|
|
|
In: Clinical Infectious Diseases, 2015, vol. 61, no. 12, p. 1894-1895
|
In: Nephrology Dialysis Transplantation, 2007, vol. 22, no. 11, p. 3330-3333
|
In: The Journal of Infectious Diseases
|
In: Clinical Infectious Diseases, 2015, vol. 61, no. 4, p. 619-622
|
In: The Journal of Infectious Diseases, 2015, vol. 211, no. 10, p. 1646-1657
|